New imaging techniques shed light on RPE role in AMD

New imaging techniques shed light on RPE role in AMD

Advances in imaging technologies such as spectral domain optical coherence tomography (SD-OCT) and polarization-sensitive OCT (PS-OCT) have significantly enhanced understanding of the anatomy and function of retinal pigment epithelium (RPE) and its role in degenerative diseases such as age-related macular degeneration (AMD), Ursula Schmidt-Erfurth MD told the 14th EURETINA Congress.

“In-vivo high-resolution imaging using a multimodal OCT system allows identification of photoreceptors and RPE disease and highlights pathophysiologic mechanisms in a quantitative and qualitative manner in all subtypes and stages of AMD,” she said.

Dr Schmidt-Erfurth noted that the RPE is a key structure in AMD pathology, with a number of structural changes occurring with increasing age.

“With age, human RPE accumulates two complex granules containing melanin – melanolipofuscin and melanolysosomes – which are polarized by laser light,” she said.

Dr Schmidt-Erfurth explained that melanosomes, melanolipofuscin and lipofuscin are the principal intracellular organelles of RPE.

“Biosynthetic enzymes localise to the organelle surface suggesting that RPE melanosomes have a dynamic turnover process,” she said.

SD-OCT allows clinicians to see depolarizing structures transformed to a quantity called Degree of Polarization Uniformity (DOPU), while polarization-sensitive OCT is capable of measuring an intrinsic tissue property known as the polarization scrambling effect, she said.

The PS-OCT in drusen allows for individual prognosis versus genetic risk calculation using a standard tool, said Dr Schmidt-Erfurth. 

“It offers a method offering quantitative data sets and reliable automated algorithms. Qualitative identification of drusen morphology gives us valuable insight into mechanisms of RPE pathology and disease progression,” she said.

Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...